FDA Modernizes Inspections: Alternative Tools Accelerate Drug Approval

Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA

The FDA (Food and Drug Administration) has finalized its guidance on using alternative tools for routine inspections of drug manufacturing facilities. The measure aims to optimize the new product approval process by using remote methods to assess compliance with Good Manufacturing Practices (GMP).

Japan’s PMDA Remote Inspections

The PMDA clarifies its requirements for conducting remote compliance inspections related to drugs and regenerative medical products.

How Cosmetic companies can stay complaint online during the COVID-19 Pandemic

The pandemic has produced new obstacles for all businesses including the cosmetic industry. the pandemic has produced a shift from shopping in stores to shopping online. the online platform is new media to many businesses and with it brings its own obstacles such as regulation requirements that differ by country.

Regulatory Challenges faced by Cosmetic Companies

cosmetics in store

Cosmetics is a dynamic industry, with new novel products ready to market it puts significant pressure on companies to understand global regulation and registration processes in order to reach consumers and markets globally.